Labbate, Craig V.
25  results:
Search for persons X
?
2

Longitudinal GFR trends after neoadjuvant chemotherapy prio..:

Labbate, Craig V. ; Hensley, Patrick J. ; Miest, Tanner S....
Urologic Oncology: Seminars and Original Investigations.  40 (2022)  10 - p. 454.e17-454.e23 , 2022
 
?
3

AUTHOR REPLY:

Labbate, Craig V ; Kuchta, Kristine ; Park, Sangtae..
Urology.  164 (2022)  - p. 177 , 2022
 
?
4

The association of salvage intravesical therapy following B..:

Packiam, Vignesh T. ; Labbate, Craig V. ; Boorjian, Stephen A....
Urologic Oncology: Seminars and Original Investigations.  39 (2021)  7 - p. 436.e1-436.e8 , 2021
 
?
6

National management trends in clinical stage IIA nonseminom..:

Labbate, Craig V. ; Werntz, Ryan P. ; Galansky, Logan B...
Urologic Oncology: Seminars and Original Investigations.  38 (2020)  8 - p. 687.e13-687.e18 , 2020
 
?
7

Inherited risk assessment of prostate cancer: it takes thre..:

Xu, Jianfeng ; Labbate, Craig V. ; Isaacs, William B..
Prostate Cancer and Prostatic Diseases.  23 (2019)  1 - p. 59-61 , 2019
 
?
9

First analysis of the safety and efficacy of UGN-101 in the..:

Jacob, Joseph M. ; Woldu, Solomon L. ; Linehan, Jennifer...
Urologic Oncology: Seminars and Original Investigations.  42 (2024)  1 - p. 20.e17-20.e23 , 2024
 
?
12

The ablative effect of mitomycin reverse thermal gel: Expan..:

Kaimakliotis, Hristos Z. ; Tachibana, Isamu ; Woldu, Solomon...
Urologic Oncology: Seminars and Original Investigations.  41 (2023)  9 - p. 387.e1-387.e7 , 2023
 
?
13

Early experience with UGN-101 for the treatment of upper tr..:

Woldu, Solomon L. ; Labbate, Craig ; Murray, Katie S....
Urologic Oncology: Seminars and Original Investigations.  41 (2023)  3 - p. 147.e15-147.e21 , 2023
 
1-15